Concepedia

Rohan Diwanji

RD

Statistics

Publications

7

Citations

558

H-Index

7

Active since

2013

Affiliations

Dicerna Pharmaceuticals (United States)(Current)

Centre for Biomedical Network Research on Rare Diseases

Novartis (Switzerland)

Novartis (China)

Rohan Diwanji is an author at Dicerna Pharmaceuticals (United States) specializing in life sciences, oncology, and hepatic metabolism.

ORCID

Publications per year

2013–2023

7

Publications

7

TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts

Angelo L. Grauel, Beverly Nguyen, David A. Ruddy et al. · Nature Communications · 2020 · 203 citations · Full text

, , +17

Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria

Cheng-Jung Lai, Natalie W. Pursell, Jessica J. Gierut et al. · Molecular Therapy · 2018 · 106 citations · Full text

, , +13

Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1

Chaitali Dutta, Nicole Avitahl-Curtis, Natalie W. Pursell et al. · Molecular Therapy · 2016 · 83 citations · Full text

, , +15

Knockdown of β-catenin with Dicer-Substrate siRNAs Reduces Liver Tumor Burden In vivo

Henryk Dudek, Darren H. Wong, Rokhand Arvan et al. · Molecular Therapy · 2013 · 57 citations · Full text

, , +16

Effect of in vivo Hydroxychloroquine and ex vivo Anti-BDCA2 mAb Treatment on pDC IFNα Production From Patients Affected With Cutaneous Lupus Erythematosus

Agnès Gardet, Alex Pellerin, Christie‐Ann McCarl et al. · Frontiers in Immunology · 2019 · 42 citations · Full text

, , +17

1–5 of 7